HD-OPM Archive
Topics › Brain health & dementia

Meta-analysis: statin use linked to 20% lower dementia and 32% lower Alzheimer's risk

Louis Nervegna · Oct 19, 2025 · ♥ 11 reactions · 0 comments · original Facebook post
Brain health & dementiaStatins
↻ This is a repost. The main version (highest ranked) is Statin use linked to 20% lower dementia and 32% lower Alzheimer's risk in meta-analysis · Oct 22, 2024.
AI summary & key facts

Louis shares a large meta-analysis of observational studies showing statin users had lower dementia and Alzheimer's risk. Authors concluded there is no neurocognitive harm signal and a potential beneficial role, but called for dedicated randomized trials.

(no text — see the shared post below)

Research cited

In a huge meta-analysis of observational studies, statin use was associated with a 20% lower risk of dementia (36 studies), and a 32% lower risk of Alzheimer’s (21 studies).

Quoted:

“In the pooled analyses, statins were associated with a decreased risk of dementia [36 studies, OR 0.80 (CI 0.75–0.86)] and of AD [21 studies, OR 0.68 (CI 0.56–0.81)].”

“These results confirm the absence of a neurocognitive risk associated with statin treatment and suggest a potential favourable role of statins. Randomized clinical trials with an ad hoc design are needed to explore this potential neuroprotective effect.”

#statinsdementiaHD #ldldementiaHD #statinsHD #dementiaHD #alzheimersHD

← newer: Methotrexate may lower heart disease risk in rheumatoid artholder: Humming boosts nasal nitric oxide about 15-fold; a small RCT →